Parkinson's disease in China: a forty-year growing track of bedside work

Parkinson's disease in China: a forty-year growing track of bedside work

The number and health burden of Parkinson's disease increase rapidly in China. It is estimated that China will have nearly half of the Parkinson's disease population in the world in 2030. In this review, we present an overview of epidemiology and health economics status of Parkinson's...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Translational Neurodegeneration 2019-07, Vol.8 (1), p.22-22, Article 22
Hauptverfasser: Li, Gen, Ma, Jianfang, Cui, Shishuang, He, Yixi, Xiao, Qin, Liu, Jun, Chen, Shengdi
Format: Artikel
Sprache:eng
Schlagworte:
Anopheles
Biological markers
Clinical research
Clinical trials
Developing countries
Diagnosis
Epidemiology
Medical economics
Medical research
Parkinson’s disease
Pimavanserin
Povidone
Review
Safinamide
Tertiary network
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The number and health burden of Parkinson's disease increase rapidly in China. It is estimated that China will have nearly half of the Parkinson's disease population in the world in 2030. In this review, we present an overview of epidemiology and health economics status of Parkinson's disease across China and discuss the risk factors of Parkinson's disease and related complications. From the view of clinical research, we also discuss the current status of clinical trials, diagnostic biomarkers, treatment of Parkinson's disease, tertiary network and post-occupation education in Chinese Parkinson's disease clinics.
ISSN:2047-9158
2047-9158
DOI:10.1186/s40035-019-0162-z